Evexomostat combination shows clinical benefit and favorable safety in heavily pretreated HR+/HER2− mBC patients with ...

Metabolism has always been a crucial pillar in cancer treatment, but clinical considerations have been limited to general diet and nutrition advice, minimizing the potential therapeutic impact of ...

Relay Therapeutics clinical trial results shows targeted therapy drug shrank tumors in patients rare blood vessel cancers The ...

Please provide your email address to receive an email when new articles are posted on . Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in ...

Exploratory data show inavolisib benefits persist regardless of hyperglycemia in PIK3CA-mutated breast cancer, with ...

Low-dose aspirin significantly reduced colorectal cancer recurrence in patients with PI3K pathway gene alterations, nearly halving recurrence rates over three years compared to placebo. The study ...

Experts in cell signaling at the Babraham Institute have identified how prostate cancer cells achieve cell growth free from the usual growth cues and regulators. This discovery has implications for ...

Novel estrogen receptor beta agonist S-equol decreases tumor proliferation in patients with triple negative breast cancer (TNBC). Impact of metastases directed radiation therapy on CDK4/6 inhibitors ...

In 2024, an estimated 310,720 women in the United States will be diagnosed with invasive breast cancer -- and about 80% of breast cancers are estrogen-receptor-positive, or ER+ breast cancer, making ...

Combining IL-12 immunocytokine (M9241) with docetaxel in metastatic prostate cancer: A phase I study. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not ...